Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Abbott

3 Dividend Growth Stocks To Buy and Hold Forever

These three companies have a high 5-year dividend yield, providing long-term stability while maximizing income.

Barchart

3 Dividend Aristocrats With Explosive Earnings and Bulletproof Payouts

Discover 3 Dividend Aristocrats with high earnings growth, low payout ratios, and strong analyst ratings: perfect for long-term income investors.

Barchart

Abbott Laboratories Stock: Is ABT Outperforming the Health Care Sector?

Abbott Laboratories has outperformed the Health Care sector over the past year, and analysts are highly optimistic about the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

The 3 Most Powerful Dividend Kings You’ve Probably Overlooked

These three Dividend Kings have strong cash flow and EPS growth, making a compelling case for long-term income investors.

Barchart

3 Oversold Dividend Aristocrats Wall Street Says Are Ready to Rally

Markets rise on improving geopolitical sentiment, leaving some quality dividend stocks to remain oversold.

Barchart

Is Wall Street Bullish or Bearish on Abbott Laboratories Stock?

As Abbott Laboratories has outperformed the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Wall Street’s Best-Kept Secret? These 3 Dividend Stocks Are Outperforming Big Tech

These three Dividend Kings are beating the market in 2025, offering strong yields, reliable growth, and solid analyst buy ratings.

Barchart

Read news from The Economist, FT, and more,
with one subscription

MotoAmerica Revolutionises Rapid Concussion Testing in Sport With New Blood Test

The last time a helmet saved my life, I certainly wasn't feeling right for some time. I was dizzy, to say the least, but did I have a concussion? I don't know, and that's a problem in motorcycle racing. I continued to ride that day, but if I'd had Abbott's…

RideApart

2025 Boston Marathon: Sharon Lokedi Shatters Course Record in Dominant Win

Lokedi broke the course record with a time of 2:17:22.

Sports Illustrated

Tariff-Resistant Abbott Laboratories on Track for New Highs

Abbott Laboratories stock price is on track to hit a new high in 2025 and could do it before the end of the first half. Dividends and buybacks help.

MarketBeat

Abbott Elementary is Hulu's #3 most-watched show – here are 3 more comedies with over 90% on Rotten Tomatoes to stream

It's nearly the end of term for Abbott Elementary season 4, but school's in for these three comedies.

TechRadar

Here’s What to Expect From Abbott Laboratories’ Next Earnings Report

Abbott Laboratories is expected to announce its first-quarter results this month, and analysts predict a single-digit growth in the company’s bottom-line figure.

Barchart

Jake Arnold's L.A.-meets-London outdoor collection with Crate & Barrel is giving me the motivation to springboard my new season patio makeover

When the inspo is this good, you want to buy into it immediately

Homes & Gardens

Nearly 20 infant formulas found to contain toxic lead, arsenic, or both. Here's how parents can keep babies safe

“We really want these results to be empowering for parents,” said Consumer Reports, which tested 41 types of baby formula.

Fortune

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is Abbott Laboratories Stock Outperforming the Dow?

Abbott Laboratories has notably outpaced the Dow Jones Industrial Average over the past year and analysts remain strongly bullish on the stock’s prospects.

MarketBeat

Abbott Laboratories Will Outperform Healthcare Stocks in 2025

Johnson & Johnson and Abbott Laboratories offer substantial opportunities for investors, but one is a better buy for total returns in 2025 and 2026.

Barchart

Earnings Preview: What to Expect From Abbott's Report

Abbott will release its fourth-quarter earnings later this month, and analysts anticipate a double-digit bottom-line growth.

Barchart

Love Dividends? 2 Passive Income Stocks to Scoop Up Now.

These consistent dividend-paying stocks could be a good addition to your portfolio.

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

How Abbott Labs Became a Dividend Growth Investor's Dream

Abbott Laboratories is one of the best dividend stocks to buy today: here's why.

StockNews.com

3 Healthcare Stocks to Buy Now for a Healthy Portfolio in 2025

The healthcare industry is set for growth due to the growing demand for quality treatments and ongoing progress in medical technology. Hence, investors might consider investing in healthcare stocks, Eli Lilly (LLY), Thermo Fisher Scientific (TMO), and Abbott Laboratories (ABT) for a healthy portfolio in 2025. Read more….

WhatToWatch

Abbott Elementary celebrates the holidays with two new episodes tonight, December 4

Abbott Elementary season 4 is winding down the year with two new holiday episodes on December 4. Here’s what you need to know about the special event.

Barchart

Is Abbott Laboratories Stock Underperforming the Nasdaq?

Despite Abbott Laboratories’ underperformance relative to the broader Nasdaq Composite over the past year, Wall Street analysts remain bullish about the stock’s prospects.

WhatToWatch

Why Abbott Elementary is not new tonight, November 27

Abbott Elementary is not new tonight, November 27. Here’s when fans can expect to see another new episode.

Barchart

What Are Wall Street Analysts' Target Price for Abbott Laboratories Stock?

Despite Abbott Laboratories’ underperformance relative to the broader S&P 500 Index over the past year, Wall Street analysts maintain a bullish outlook about the stock’s prospects.

The Guardian - UK

‘If they don’t get care, they die’: the woman who runs the world’s largest kidney dialysis company

Helen Giza of FME is excited about the possibilities new drugs such as Ozempic could offer for renal patients

1 2 3 4 5

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.